कोशिश गोल्ड - मुक्त
India's 2026 GDP data revision is about methods, not growth rates
Mint Chennai
|December 24, 2025
Discussion papers published by the statistics ministry should cue debates on what India can reasonably expect to measure
Following the release of two discussion papers by India's ministry of statistics outlining proposed methodological changes for the upcoming base-year revision of national accounts, there has been a renewed focus on our methodology for the GDP revision.
The new base year will be 2022-23 and the revised series is scheduled for release in early 2026. They lay out, in great detail, what has changed in data availability and show improvements in methodology.
It is precisely for these reasons that they deserve attention. They do not settle our perennial and politicized debates about India's 'true' growth rates. Instead, they represent a significant step in how the statistical system explains itself to users, while also giving us the tools to understand what constraints remain.
On the positive side, these revisions build on previous efforts and incorporate newer data available since the 2011 series to move away from blunt proxies and static ratios. On the production side, the expanded use of corporate filings (via MGT 7/7A forms filed with the ministry of corporate affairs), enables a more efficient allocation of value added across activities, rather than assigning multi-activity firms wholesale to a single dominant sector. The use of India's Annual Survey of Unincorporated Sector Enterprises (ASUSE) and Periodic Labour Force Survey (PLFS) makes household sector estimates more dynamic than the practice of using proxies for growth on base-year estimates. In the past, such simplifications were unavoidable; today, richer administrative and survey data permit more granular treatment. These changes will not lead to higher or lower growth, but will improve consistency.
यह कहानी Mint Chennai के December 24, 2025 संस्करण से ली गई है।
हजारों चुनिंदा प्रीमियम कहानियों और 10,000 से अधिक पत्रिकाओं और समाचार पत्रों तक पहुंचने के लिए मैगज़्टर गोल्ड की सदस्यता लें।
क्या आप पहले से ही ग्राहक हैं? साइन इन करें
Mint Chennai से और कहानियाँ
Mint Chennai
India's first class action hits snag as lead petitioner exits
Lead shareholder Ankit Jain has sought to exit the class action suit against Jindal Poly Films
2 mins
April 10, 2026
Mint Chennai
Panel to assess health insurers’ concerns
In an effort to improve policyholder experience and penetration of health insurance in the country, the Insurance Regulatory and Development Authority of India (Irdai) has constituted a subcommittee of the Insurance Advisory Committee.
1 mins
April 10, 2026
Mint Chennai
From access to agency: Reset the goal for women's empowerment
Increased participation in the Indian economy isn't sufficient. Women should be empowered to shape our economic outcomes
3 mins
April 10, 2026
Mint Chennai
Why Iran thinks it won the war despite huge military losses
When Iran agreed to a two-week ceasefire only hours before President Trump had vowed to unleash punishing new attacks, it was in many ways a moment of triumph for the battered regime.
4 mins
April 10, 2026
Mint Chennai
Of food, art and a drag show
A Mint guide to what's happening in and around your city
1 min
April 10, 2026
Mint Chennai
Is the US-Israel-Iran ceasefire a pause or tactical turning point?
This conflict’s trajectory will depend on whether the adversaries can resolve its structural drivers
3 mins
April 10, 2026
Mint Chennai
LNG supply woes spur India's compressed biogas push
Govt to streamline initiatives aimed at promoting biogas.
1 mins
April 10, 2026
Mint Chennai
Phoenix offers cheaper retail proxy. Real estate is the risk
Shares of The Phoenix Mills Ltd have risen 7% in the past two sessions, buoyed by its Q4FY26 business update.
1 mins
April 10, 2026
Mint Chennai
SECOND LIFE: RMG OUTFITS TRY NEW PLAYING FIELDS
Six months after real-money gaming was banned, the industry is trying to reboot.
8 mins
April 10, 2026
Mint Chennai
Govt to bar private lab tests of vaccines, biological products
India plans to restrict the testing of vaccines and specialized biological products exclusively to government-controlled laboratories to maintain quality standards, according to two government officials and documents reviewed by Mint.
1 min
April 10, 2026
Listen
Translate
Change font size
